Genetic and epigenetic alterations such as BRCA1/2 mutations have also been shown to affect the risk of lifetime breast cancer [10,11] whereby the risks increase to 65–81% for those with BRCA1 mutation carriers and 45–85% for BRCA2 mutation carriers [12,13]. Here, BRCA1 is linked to breast carcinoma.